Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, reposted from Takeda on LinkedIn:
”Imagine needing a treatment so rare, so specific, that only plasma-derived medicine can help.
For hundreds of thousands of people around the world, this is their reality – and their hope.
At BioLife Plasma Services, our employees are the heartbeat of this hope.
We welcome donors with care, ensure safety at every step, and help transform each donation into life-sustaining medicine.
I’m inspired by the work of Thomas – and all our employees – every day.”
Takeda shared on LinkedIn:
”Plasma is required to produce life-sustaining medicine for people with rare and serious health conditions and can’t be manufactured. It’s a precious gift that comes from generous donors. But how does this life-sustaining resource get from donor to patient?
It takes dedication, care and a whole lot of heart. Our colleagues at BioLife Plasma Services are the vital starting point in this journey – ensuring a safe and welcoming experience for every donor, and collecting the plasma that transforms lives.
This International Plasma Awareness Week (IPAW), get an inside look at the inspiring work to help maintain a reliable supply of plasma for patients.”
Read more here.
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants